What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly announce and furnish Boston Scientific Corporation's financial results for the third quarter ended September 30, 2016, through an accompanying press release.

Where can I find the detailed financial results and analysis?

The detailed financial results, including revenue, earnings, and other performance metrics, are contained within the press release issued by Boston Scientific dated October 26, 2016, which is furnished as Exhibit 99.1 to this 8-K filing.

Does this filing include any forward-looking statements or guidance updates?

This filing itself, as an 8-K, primarily serves to report historical financial results. Any forward-looking statements, guidance, or strategic commentary will be found within the furnished press release (Exhibit 99.1) and should be reviewed carefully by investors.

Is the information in this 8-K considered 'filed' for legal purposes?

No, the information contained in Item 2.02 of this Current Report and Exhibit 99.1 is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. It is also not deemed incorporated by reference into any other filing.

BSX 8-K: Earnings & Results

Summary

Boston Scientific Corporation (BSX) filed an 8-K on October 26, 2016, primarily to announce its third-quarter financial results for the period ended September 30, 2016. The press release detailing these results, furnished as Exhibit 99.1, is the central piece of information for investors in this filing. Investors should review this press release for key performance metrics, revenue figures, and any commentary provided by management on the company's operational and financial condition during the quarter.

Key Highlights

1The 8-K filing's main purpose is to disseminate Boston Scientific's third-quarter 2016 financial results.
2The detailed financial results and management's commentary are available in the press release furnished as Exhibit 99.1.
3This filing does not contain new operational or strategic disclosures beyond the Q3 earnings announcement.
4The information provided is for the period ending September 30, 2016.
5Investors are directed to the press release for an in-depth understanding of the company's performance and financial position during Q3 2016.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Oct 26, 2016)

Summary

Key Highlights

Frequently Asked Questions